What does Espey Mfg. & Electronics Corp. do?
Espey Mfg. & Electronics Corp. is a small, specialized U.S. power-electronics manufacturer listed on the NYSE American under ticker ESP. The company designs, manufactures, qualifies, and supports high-reliability power conversion and magnetic products for military, rail, and other severe-environment applications. Its official company overview describes a product set spanning power supplies, converters, filters, transformers, magnetic components, distribution equipment, uninterruptible power systems, antennas, and related engineering services.
Which products and customers define the company?
Espey’s products sit inside platforms where electrical reliability, qualification history, and long service lives matter more than consumer-style product cycles. Applications include shipboard power and radar, airborne and ground-based radar, ground-mobile power, AC and DC locomotives, submarine systems, and other military or rugged industrial equipment. The company sells to large defense contractors, U.S. government agencies, foreign governments, and industrial manufacturers. It may act as a direct Department of Defense contractor or as a supplier to a prime contractor.
| Identity factor | Officially reported detail | Analytical implication |
|---|---|---|
| Listing | NYSE American, ticker ESP | A publicly traded micro-cap manufacturer with smaller-reporting-company disclosures. |
| Certifications | ISO 9001:2015 and AS9100:2016 | Quality systems are part of qualification credibility in aerospace and defense supply chains. |
| Operating footprint | Single 174,000+ square foot Saratoga Springs facility | Concentrated control and vertical integration, but also single-site operational exposure. |
| Geography | Primarily domestic; FY2025 exports were $3.1 million | U.S. defense budgets and domestic industrial-base policy drive more of the story than foreign demand. |
Why is one reportable segment still economically diverse?
Accounting presents one segment, but program economics differ. Mature production and build-to-print work can earn better margins than development programs requiring design, testing, or upfront investment. Product mix, milestone timing, and program maturity therefore matter more than a conventional segment-growth comparison.
How does Espey make money?
Espey earns revenue under fixed-price contracts for engineered products, recurring production units, build-to-print manufacturing, field service, environmental testing, and design milestones. The FY2025 Form 10-K explains that actual profit depends on whether labor, material, subcontracting, and overhead costs remain within the estimates used when the contract price was negotiated.
How concentrated is the customer base?
Customer concentration is high because individual programs are large relative to Espey’s revenue. In Q3 FY2026, five customers generated 73% of sales; the largest represented 20%. For the first nine months, four customers generated 61%. One customer may span several programs, but a major program loss or funding delay can still move annual results materially.
| Revenue driver | Q3 / nine-month FY2026 evidence | What improves economics | What pressures economics |
|---|---|---|---|
| Production units | $28.7M for nine months ended March 31, 2026 | Mature designs, repeat volumes, stable labor routings | Component shortages, delivery delays, unfavorable mix |
| Milestones | $3.9M for nine months ended March 31, 2026 | Timely approvals and disciplined engineering execution | Customer approval delays and technical rework |
| Build-to-print | Included within the single segment; not separately disclosed | Lower design risk and efficient vertical manufacturing | Pricing competition and input-cost inflation |
| Field service and testing | A specific field-service job supported Q3 FY2026 growth | Installed-base knowledge and customer continuity | Project timing and limited disclosure by service line |
What does Espey’s latest reported quarter show?
The latest official package covers the quarter ended March 31, 2026. Espey’s Q3 FY2026 Form 10-Q and official results release show sales up 10.9%, gross profit up 43.5%, and operating income up 70.4%.
Why did profitability improve faster than revenue?
Management attributed growth to magnetics programs and a field-service job, partly offset by weaker power-supply and build-to-print work. Gross margin rose from 28.6% to 37.0%, reflecting favorable mix, labor efficiency, and process improvements. SG&A increased only 4.1%, allowing much of the gross-profit gain to reach operating income.
| Metric | Q3 FY2026 | Q3 FY2025 | Change / interpretation |
|---|---|---|---|
| Net sales | $11.4M | $10.3M | Up 10.9%; stronger magnetics and field service outweighed weaker programs elsewhere. |
| Gross profit | $4.2M | $2.9M | Up 43.5%; product mix and execution improved. |
| Operating income | $3.0M | $1.8M | Up 70.4%; SG&A growth remained limited. |
| Net income | $2.9M | $1.7M | Up 68.1%; interest income also contributed. |
| Diluted EPS | $0.99 | $0.63 | Up 57.1% despite a higher diluted share count. |
How does the nine-month picture differ?
Year-to-date sales declined while profitability improved. New orders were $30.0 million versus $75.1 million a year earlier, making future backlog replenishment an important watch item.
Why do backlog, fixed-price contracts, and program mix drive Espey’s economics?
At March 31, 2026, backlog was $137.1 million, nearly unchanged year over year and about 3.1 times FY2025 revenue. It provides visibility, but delivery schedules, engineering milestones, and fixed-price costs can shift before revenue is recognized.
How quickly can backlog become revenue?
The FY2025 annual report scheduled the $139.7 million June 2025 backlog across FY2026, FY2027, FY2028, and later years. The long tail supports production visibility but makes quarterly forecasting less linear.
Why can a growing backlog still produce uneven margins?
Espey may absorb upfront design expense to win programs with long production tails. Mature products usually earn better margins than development-stage work, while engineering rework, testing, inflation, supplier delays, or underestimated costs can pressure profit. Inventory and contract cost estimates were the FY2025 critical audit matter because revised estimates affect current earnings.
What strategic turning points still shape Espey today?
Espey’s development centers on qualification knowledge, in-house capability, and industrial-base investment rather than frequent acquisitions. Its official history connects decades of military programs to today’s submarine and naval opportunities.
Which events changed the current opportunity set?
-
1928Incorporation in New York established the long operating history that now supports qualification credibility and customer continuity.
-
1988The employee stock ownership plan became effective, creating a workforce-linked ownership structure that remains a major voting and economic influence.
-
2022David O’Neil became president and chief executive officer after serving in senior financial and operating roles since 2000, reinforcing management continuity.
-
2023A $7.4 million Navy funding award supported facility expansion and test capability for the Surface Combatant Industrial Base.
-
2024A $29.5 million contract award, when fully funded, added Columbia-class submarine power-distribution work.
-
2025An additional $19.8 million contract award, when fully funded, expanded transformer work for Virginia- and Columbia-class submarine programs.
-
2025A further $3.4 million Navy-funded capital program strengthened domestic design, manufacturing, testing, and qualification capacity, with completion targeted by FY2026.
Espey remains a compact, single-site manufacturer, but its backlog and facility investments increasingly connect it to large naval programs. That can extend production tails while increasing execution, funding, and labor dependence.
What gives Espey a competitive advantage?
Espey does not claim broad market leadership. Its narrower advantage combines qualification history, engineering knowledge, small-company agility, and vertical integration. The military power systems and magnetics portfolio also identifies sole-source positions in certain naval transformer applications, where technical requirements and requalification can constrain replacement.
How does vertical integration create value?
What limits the moat?
Competition ranges from large electronics divisions to small specialists, some willing to fund design work or accept lower margins. Concentrated buyers also impose demanding technical, cost, and schedule terms. Espey’s advantage must therefore be renewed through execution, pricing discipline, workforce retention, and follow-on awards.
How financially strong is Espey?
Espey’s balance sheet is highly liquid. At March 31, 2026, cash was $21.2 million and investments were $25.5 million. The company reported no borrowings, an unused $3.0 million credit line, and $50.5 million of working capital. Contract liabilities of $33.5 million mainly represent customer advances rather than debt.
What does the annual baseline show?
| Financial measure | FY2025 | FY2024 | Interpretation |
|---|---|---|---|
| Revenue | $44.0M | $38.7M | Up 13.5%, supported by program shipments and milestones. |
| Gross margin | 28.9% | 27.5% | Improved, but below the 35.7% achieved in the first nine months of FY2026. |
| Operating margin | 18.5% | 16.9% | Shows meaningful operating leverage when mix and execution cooperate. |
| Net income | $8.1M | $5.8M | Net margin reached 18.5%; interest income helped. |
| Operating cash flow | $21.0M | $10.6M | FY2025 benefited heavily from a $13.8 million increase in contract liabilities. |
| Capital expenditures | $4.4M | $5.2M | Partly reimbursed by Navy grants: $3.3 million in FY2025. |
How should cash flow be interpreted?
Cash conversion is lumpy. In the first nine months of FY2026, inventories increased $8.7 million and prepaid or other current assets rose $5.7 million, partly offset by a $10.6 million increase in contract liabilities. A DCF should normalize these movements rather than annualize one period.
How does Espey allocate capital?
Espey combines facility investment with dividends and conservative liquidity. It paid $4.1 million of dividends in the first nine months of FY2026, including a special dividend, while maintaining a $0.25 quarterly rate. Remaining repurchase authorization was $783,460, but dividends remained the primary return tool.
Who owns Espey stock, and why does governance matter?
Espey has one vote per common share, but the employee retirement plan and trust is the largest disclosed holder. The 2025 proxy reported 547,370 shares, or 18.66%, as of October 16, 2025. Participants direct allocated shares; trustees handle unallocated shares under plan rules and ERISA.
What does the ESOP change?
| Holder / governance group | Ownership or structure | Source period | Why it matters |
|---|---|---|---|
| Employee retirement plan and trust | 547,370 shares; 18.66% | October 16, 2025 | Links employee wealth to the stock and creates meaningful voting influence. |
| Directors and executive officers as a group | 140,640 direct plus 17,048 indirect shares; 5.54% | October 16, 2025 | Management and directors have economic exposure, but no single executive controls the company. |
| David O’Neil, president and CEO | 29,106 direct plus 15,544 indirect shares; 1.6% | October 16, 2025 | Long tenure and stock exposure support continuity, while the independent board remains important. |
| Board structure | Five directors; four classified as independent | 2025 proxy | A classified board and long director tenures can favor continuity over rapid change. |
How are management incentives linked to operations?
The chief executive’s 2025 agreement links bonus opportunity to sales plus backlog growth and operating earnings at a stated margin threshold. The design balances demand creation with profitability, but researchers should still test whether new awards convert into cash and acceptable margins.
What opportunities and risks could change Espey’s outlook?
Upside depends on backlog conversion, naval-program growth, capacity utilization, and durable margins. Risks center on concentration, fixed-price execution, supply constraints, labor, funding, and approval timing.
Which growth drivers deserve attention?
Which filing risks are most material?
| Risk | Official evidence | Financial line affected | What to monitor |
|---|---|---|---|
| Customer concentration | Five customers were 73% of Q3 FY2026 sales | Revenue, receivables, backlog | Program losses, award delays, or customer-specific schedule changes |
| Fixed-price execution | Cost-to-complete estimates can create loss contracts | Inventory, cost of sales, gross margin | Testing rework, engineering overruns, estimate revisions |
| Supply chain and obsolescence | Certain components have lead times approaching one year or limited sources | Inventory, delivery timing, working capital | Supplier lead times, alternate-part approvals, tariff effects |
| Specialized labor | Longer hiring times for certain skill sets in a tight local market | Throughput, labor efficiency, SG&A and overhead | Headcount, union relations, overtime, delivery schedules |
| Government dependence | Military programs depend on budgets, appropriations, approvals, and termination rights | Backlog conversion and revenue timing | Funded backlog, program appropriations, customer approvals |
A disruption at the single Saratoga Springs site could affect engineering, production, and testing simultaneously. Liquidity can absorb delays but cannot replace lost throughput.
Why does Espey’s business model matter for valuation?
A simple revenue-growth DCF can misread Espey because sales depend on milestones, shipment mix, and long schedules. Modeling should begin with funded backlog conversion, new orders, and normalized margins, while separating operating value from excess cash and investments.
Which valuation drivers matter most?
| DCF driver | Current evidence | Modeling implication |
|---|---|---|
| Backlog conversion | $137.1M at March 31, 2026; about 89.4% funded | Use a multi-year conversion schedule and include delivery slippage sensitivity. |
| Order replenishment | $30.0M new orders in first nine months of FY2026 | Terminal growth requires replacement of delivered backlog with new awards. |
| Normalized gross margin | 28.9% in FY2025; 35.7% in first nine months of FY2026 | Use a range rather than assuming the latest favorable mix is permanent. |
| Working capital | Inventory rose $8.7M in first nine months of FY2026; contract liabilities rose $10.6M | Forecast advances and inventory together; both can distort cash flow. |
| Excess liquidity | $46.7M cash and investments at March 31, 2026 | Value operating cash separately from capital not required to run the business. |
| Capital returns | $1.50 dividends per share in first nine months of FY2026, including a special dividend | Distribution policy affects equity value but should not substitute for operating cash-flow analysis. |
Comparable analysis is difficult because Espey combines defense exposure, power electronics, an ESOP, and a cash-rich micro-cap balance sheet. Scenario analysis should test steady conversion, durable mid-30% gross margins, and a pressure case with slower orders and working-capital absorption.
What should students, researchers, and investors watch next?
Espey matters because it holds specialized positions in power conversion and magnetics for long-lived defense platforms. Its story combines backlog above three times FY2025 revenue, improving margins, strong liquidity, Navy-supported capacity, and meaningful employee ownership.
- New orders versus sales: backlog remains large, but order replenishment weakened in the first nine months of FY2026.
- Funded backlog: track whether the approximately $14.5 million unfunded portion at March 31, 2026 receives appropriations.
- Gross margin: determine whether the 35.7% nine-month FY2026 level survives changes in product mix.
- Contract-cost estimates: watch inventory growth, loss-contract charges, and testing or engineering overruns.
- Cash conversion: separate earnings from movements in customer advances, inventories, receivables, and grants.
- Naval capacity utilization: measure whether funded facility upgrades translate into deliveries and follow-on awards.
- Customer concentration: monitor the largest programs rather than relying only on total customer counts.
- Capital allocation: compare dividends and possible repurchases with reinvestment needs and excess liquidity.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.